Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,108.09 +44.05 (+4.14%)
Official Closing Price Updated: 4:10 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Eli Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal ↗
Lilly will acquire all of the outstanding shares of Ventyx for $14 per share of common stock in an all-cash transaction. 
Via Stocktwits
News headline image
3 Drug Stocks to Buy at a Discount ↗
The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap industry giants to consider. 
Via The Motley Fool
News headline image
The Valuation Wall: Nasdaq Momentum Stalls as the 'Great Rotation' of 2026 Takes Hold
The relentless surge that propelled the technology sector to historic heights throughout 2024 and 2025 has hit a significant roadblock in the opening week of 2026. As of January 7, 2026, the tech-heavy... 
Via MarketMinute
Topics Artificial Intelligence Economy
Eli Lilly Stock Rises After Hours On UBS ‘Buy’ Call Ahead Of Oral Obesity Pill Launch — GLP-1 Battle With Novo Heats Up ↗
Via Stocktwits
News headline image
The Great Rotation: How the 2026 Market Rally Outgrew the 'Magnificent Seven'
As the first week of trading in 2026 comes to a close, the S&P 500 has once again shattered records, crossing the 7,500 threshold with a momentum that feels fundamentally different from the... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
This Could Be Key to Pfizer's Turnaround in 2026 ↗
Pfizer's been focusing on a hot area of healthcare recently: GLP-1 drugs. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Eli Lilly Shares Surge On Report Of Potential Ventyx Acquisition ↗
Eli Lilly shares are trading higher Wednesday following a report suggesting the company is nearing a deal for Ventyx Biosciences. 
Via Benzinga
Discover which S&P500 stocks are making waves on Wednesday. ↗
Via Chartmill
News headline image
The Alpha Renaissance: Goldman Sachs Reports Record Hedge Fund Gains in 2025
In a landmark year for active management, Goldman Sachs (NYSE: GS) has released its comprehensive 2025 year-end report, revealing that the hedge fund industry staged a dramatic comeback, delivering... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Why Did Eli Lilly Shares Surge Today? Key Factors ↗
Eli Lilly shares surged over 4.5% on analyst upgrades, acquisition rumors involving Ventyx Biosciences, and a new $1.3 billion research partnership. 
Via Talk Markets
News headline image
Eli Lilly (LLY) Stock Is Up, What You Need To Know
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.3% in the morning session after the company announced a partnership to develop a new oral obesity drug and was reported to be in... 
Via StockStory
Topics Artificial Intelligence
News headline image
My Top 5 Stocks to Buy in Early 2026 ↗
These companies are leaders in their fields. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Ventyx (VTYX) Shares Soar 62.5% Overnight, Here&#39;s What&#39;s Going On With This Trending Stock ↗
Ventyx shares jumped in after-hours trading following reports that Eli Lilly is in advanced talks to acquire the biopharma company for over $1 billion. 
Via Benzinga
News headline image
Warning: This Skyrocketing Stock Has a Hidden Risk ↗
Novo Nordisk's new GLP-1 pill highlights the risk that Eli Lilly faces, as investors reward it for being at the forefront of the weight loss market. 
Via The Motley Fool
News headline image
Should Investors Be Concerned About This Pharmaceutical Giant's Latest Clinical Trial? ↗
Novo Nordisk has some good GLP-1 news, but is the company's failed Alzheimer's trial a long-term problem? 
Via The Motley Fool
Topics Intellectual Property
News headline image
Ventyx Biosciences Launches On Rumored $1 Billion Eli Lilly Takeover ↗
Shares of Ventyx Biosciences launched late Tuesday on reports Eli Lilly could be nearing a $1 billion deal to buy the company. 
Via Investor's Business Daily
News headline image
The Trillion-Dollar Pivot: Eli Lilly Unleashes Volume-Led Strategy to Cement Obesity Market Dominance in 2026
As of January 6, 2026, the landscape of the pharmaceutical industry has been fundamentally reshaped by Eli Lilly and Company (NYSE:LLY), which recently became the first healthcare entity to surpass a... 
Via MarketMinute
Topics Economy
News headline image
S&P 500 Shatters Records: Index Crosses 6,944 as Tech Giants and Healthcare Titans Lead the Charge
The S&P 500 reached a historic milestone on January 6, 2026, closing at a new all-time high of 6,944.82. This 0.6% gain on the first full trading week of the year signals a powerful continuation of the... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Ventyx Biosciences Stock Jumps On Reports Of Eli Lilly Buyout ↗
A deal for Ventyx could be announced imminently, the Wall Street Journal reported, citing people familiar with the matter. 
Via Stocktwits
News headline image
Eli Lilly Inks Deal With Nimbus Therapeutics To Find New Obesity Drug With AI ↗
Under the deal, Nimbus is eligible to receive up to $1.3 billion. 
Via Stocktwits
News headline image
The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026
As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
The Great 2026 Pivot: Tech and Healthcare Surge as Broader Market Rally Hits a Wall
As the first week of 2026 comes to a close, the financial markets are undergoing a significant structural shift. The broad-based "rising tide" that lifted almost all sectors throughout 2025 has begun... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Should You Buy Eli Lilly Before It Reaches $1 Trillion in Market Value? ↗
Eli Lilly offers investors safety and growth. 
Via The Motley Fool
News headline image
Arrowhead Says Its Gene Silencer Doubled Zepbound's Weight Loss ↗
Arrowhead Pharmaceuticals said Tuesday its gene-silencing approach almost doubled the four-month weight-loss with tirzepatide. 
Via Investor's Business Daily
News headline image
Motley Fool Money: Stock Market Naughty and Nice List ↗
There were nice companies and great CEOs in 2025, but also some duds. We discuss the stocks on each list and end by going shopping for stocks. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Eli Lilly Heads Toward A Defining 2026 — Can It Stay Ahead Of Novo Nordisk In The GLP-1 Showdown? ↗
Several clinical readouts and regulatory decisions are scheduled for Eli Lilly in 2026. 
Via Stocktwits
News headline image
Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗
The development comes as attention remains on Hims’ longer-term business expansion initiatives. 
Via Stocktwits
News headline image
2 Cash-Producing Stocks to Keep an Eye On and 1 We Ignore
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
Prediction: The S&P 500 $1 Trillion Club Will Double Between 2026 and 2030 ↗
Several companies could see massive gains by 2030 to join the vaunted club. 
Via The Motley Fool
Topics Stocks
News headline image
The 2026 Blueprint: Five Core Stocks to Anchor Your Portfolio in a Year of AI Realization
As we cross the threshold into 2026, the financial markets have entered a sophisticated new phase. The "AI Gold Rush" of 2024 and 2025 has matured into what analysts are calling the "Era of AI... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.